ANGELA PARRISH: Open Payments
NPI 1700612389 · RINGGOLD, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 39 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $281 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $179 |
| JAZZ PHARMACEUTICALS INC. | 1 | $133 |
| Novocure Inc. | 1 | $129 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Astellas Pharma US Inc | 1 | $103 |
| Incyte Corporation | 4 | $98 |
| Daiichi Sankyo Inc. | 3 | $87 |
| Aveo Pharmaceuticals, Inc. | 2 | $80 |
| Eisai Inc. | 2 | $44 |
| Janssen Biotech, Inc. | 1 | $29 |
Products named: ZIIHERA, Optune Lua (NovoTTF-200T), Vyloy, MONJUVI, SCEMBLIX, FOTIVDA, TAGRISSO, DATROWAY.
Industry payments across GA — which companies pay providers there.
